Clinical Trial Update: Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity [Phase 2]

View source ↗

Summary

A Phase 2 trial of photodynamic therapy using HPPH for squamous cell carcinomas of the lip, oral cavity, and oropharynx has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lip
• Squamous Cell Carcinoma of the Oral Cavity
• Squamous Cell Carcinoma of the Oropharynx
• Verrucous Carcinoma of the Oral Cavity

Drugs mentioned

• HPPH (HPPH)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx | Phase 2 | Status: WITHDRAWN